Bliss raises $17.5M Seed round to bring AI to cosmetic surgery

In a bid to bring the rapidly expanding world of cosmetic procedures into the digital age, Bliss Aesthetics, a platform that uses artificial intelligence to match patients with providers and visualize surgical outcomes, has raised $17.5 million in Seed funding. The round was led by Shine Capital, with participation from Synchrony Ventures, Sheva Ventures, Point72 Ventures, and Cerca Partners.

Full list of Israeli high-tech funding rounds in 2025

Bliss, which employs 30 people split equally between Israel and the U.S., is entering a sector on the cusp of dramatic transformation. Global demand for medical aesthetic procedures is expected to surpass $200 billion within the next decade, driven in part by shifting cultural norms and growing demand from men—a segment projected to grow by 55% in the U.S. alone. Already, one in four Americans has undergone a cosmetic procedure, according to data cited by the company.

The platform’s AI foundation combines generative models like Stable Diffusion and computer vision to help prospective patients realistically preview cosmetic outcomes. Patients can then select from a pool of board-certified physicians and access financing options, offering what Bliss says is a seamless experience from visualization to procedure.

“This funding will give us the ability to harness the momentum we are experiencing,” said Gal Yosef, Bliss co-founder and CEO, who noted that the company has seen 500% growth in its provider base since launch. The platform is now expanding into five additional U.S. states.

Bliss says its tools significantly boost patient engagement, improving conversion rates from 40% to 80%. By streamlining communications and cutting down on the administrative burden for physicians, the platform also aims to give doctors more time to focus on care.

The company’s Chief Medical Officer is none other than Dr. Michael Salzhauer, the celebrity plastic surgeon better known as Dr. Miami, who co-founded Bliss. “Through working firsthand in the industry, I’ve seen the need for a seamless consumer platform like Bliss,” he said. “For physicians, the next generation of patient care will be digital-first, intuitive, and highly personalized.”

financing options, offering what Bliss says is a seamless experience from visualization to procedure.

“This funding will give us the ability to harness the momentum we are experiencing,” said Gal Yosef, Bliss co-founder and CEO, who noted that the company has seen 500% growth in its provider base since launch. The platform is now expanding into five additional U.S. states.

Bliss says its tools significantly boost patient engagement, improving conversion rates from 40% to 80%. By streamlining communications and cutting down on the administrative burden for physicians, the platform also aims to give doctors more time to focus on care.

The company’s Chief Medical Officer is none other than Dr. Michael Salzhauer, the celebrity plastic surgeon better known as Dr. Miami, who co-founded Bliss. “Through working firsthand in the industry, I’ve seen the need for a seamless consumer platform like Bliss,” he said. “For physicians, the next generation of patient care will be digital-first, intuitive, and highly personalized.”